Last reviewed · How we verify
Topical 5% fluorouracil cream
At a glance
| Generic name | Topical 5% fluorouracil cream |
|---|---|
| Sponsor | Mazandaran University of Medical Sciences |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Dermatitis
- Sleep disorder
- Pain
- Headache
- Haemorrhage
- Nasopharyngitis
- Nausea
- Fall
- Dizziness
- Acne
- Photosensitivity reaction
- Eye swelling
Key clinical trials
- Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV (NA)
- Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum (PHASE1)
- Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart (NA)
- Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients (PHASE2)
- Microneedling Alone Versus Microneedling Coupled With Either Bleomycin or 5flourouracil in the Treatment of Plantar Warts (NA)
- Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC (PHASE1)
- Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis (PHASE4)
- Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: